Drug Information

Drug General Information
Drug ID
D0RX7Z
Former ID
DNC014595
Drug Name
DEOXYCYTIDINE
Drug Type
Small molecular drug
Indication Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] Approved [544766], [551871]
Formula
C9H13N3O4
Canonical SMILES
C1C(C(OC1N2C=CC(=NC2=O)N)CO)O
InChI
1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1
InChIKey
CKTSBUTUHBMZGZ-SHYZEUOFSA-N
PubChem Compound ID
637
Target and Pathway
Target(s) Thymidine kinase Target Info Inhibitor [533569]
References
Ref 544766Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000912)
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 533569J Med Chem. 1982 Jun;25(6):644-9.Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes.